Michael V. Novinski

Michael Novinski is a co-founder and the Chief Executive Officer for Androvia LifeSciences. An experienced leader in the pharmaceutical and biotechnology fields with a special focus on reproductive health, Michael has more than 35 years of life sciences experience. He held the position of president of Organon BioSciences USA, a biopharmaceutical company focused on female reproductive health acquired by Schering-Plough Corporation and served as Executive VP, Operations and Marketing for NV Organon while residing in Europe. He has commercialized more than 15 products through FDA approval and an additional 10 on a worldwide basis.

Michael served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) for four years, and is the author of ALL for one and ONE for all, released by Tate Publishing in May 2013. He has several patents for both innovative pharmaceutical formulations and packaging, and has been recognized in Business Week, Drug Delivery Technology, and BioWorld, among other news outlets, and a contributing thought leader to Life Science Leader.